Urgent.News

What's breaking now, across thousands of outlets.

AI

Has AI’s honeymoon ended on Wall Street?

The tech-heavy Nasdaq index was indicative of this shift after plummeting 5.28% on Friday, wiping out all gains it had recorded since the start of the year.

Has AI’s honeymoon ended on Wall Street?

Despite the AI industry being a Wall Street favorite for years, investors are now expressing concern over the sector's future. The tech-heavy Nasdaq index dropped 5.28% on Friday, erasing all gains from the beginning of the year. Steve Sostick, a financial analyst with Interactive Brokers, told AFP that a substantial repricing is underway in the market.

The combined market capitalization of the "Magnificent Seven" tech stocks – Nvidia, Microsoft, Google, Apple, Amazon, Meta and Tesla – has fallen by over $4 trillion in the past month-and-a-half.

The AI investment boom has transformed from a promising technology story to a capital markets extravaganza, with billions spent on development. However, the soaring spending has led to ballooning debt, and the profits have yet to catch up. Investors are now questioning the profitability of these investments and whether the money is being spent wisely.

The AI giant Anthropic, which made its stock market debut, raised $91 billion but acknowledged future financing needs that may require borrowing. The European Central Bank has also warned about the opaque nature of AI-related debt, which is complicated by circular links in the AI supply chain.

Written by urgent.news from Free Malaysia Today's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

This story

This is one outlet's version. Read the fullest account.

Every outlet that reported this, and when →

Read the original at freemalaysiatoday.com →

More in AI

Connecting Industrial IoT and AI: Exploring Physical AI in Pharmaceutical Manufacturing

Physical AI and AIoT present interesting engineering opportunities for pharmaceutical and chemical manufacturing. By combining equipment identification, industrial sensors, and AI-driven decision…

  • Physical AI integrates with IoT in pharmaceutical manufacturing
  • Four-stage architecture includes Identify, Sense, Decide, and Act
  • Challenges include data integrity, sensor calibration, and safety

More from Saturday 21 November →